Peptide therapy should always be prescribed and supervised by a qualified practitioner, ensuring correct dosing, monitoring, and integration into a broader healing plan
Safety Profile & Considerations GHK-Cu has one of the more favourable safety profiles among research peptides, which is partly attributable to its natural occurrence in the human body
Australia, Canada, and EU In Australia, AOD9604 is classified as a prescription-only medication by the Therapeutic Goods Administration (TGA) (Poisons Standard Appendix D lists AOD9604
Allergic reaction: While rare, some individuals are allergic to injectable formulations or preservatives
Supports Angiogenesis and Wound Healing By promoting the formation of new blood vessels, GHK-Cu improves oxygen and nutrient delivery to healing tissues